{
  "id": 10513644,
  "title": "Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway",
  "url": "https://urgent.news/2026/09/28/adicet-bio-shares-promising-look-at-car-t-for-lupus-but-stock-drops",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T19:01:13.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/adicet-bio-shares-promising-look-at-car-t-for-lupus-but-stock-drops-anyway/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Adicet Bio reported that its off-the-shelf CAR-T therapy improved symptoms for lupus patients in an early-stage study, and it plans to soon start a pivotal trial. The Bay Area company in ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}